(Q45887851)

17 December 2017

title

Biosafety monitoring of patients receiving intracerebral injections of murine retroviral vector producer cells (English)

1 reference

17 December 2017

Biosafety Monitoring of Patients Receiving Intracerebral Injections of Murine Retroviral Vector Producer Cells (English)

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

26 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

author name string

Z. Long

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

L. P. Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

T. Grooms

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

C. Lockey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

K. Nader

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

I. Mychkovsky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

S. Mueller

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

I. Burimski

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

P. Ryan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

G. Kikuchi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

D. Ennist

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

S. Marcus

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

E. Otto

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

G. McGarrity

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9625255

26 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9625255

26 December 2024

publication date

1 May 1998

1 reference

17 December 2017

20 May 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9625255

full work available at URL

26 December 2024

http://www.liebertpub.com/doi/pdf/10.1089/hum.1998.9.8-1165

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

26 December 2024

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

1165-1172

1 reference

17 December 2017

cites work

Human gene therapy

1

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

Report to the NIH Recombinant DNA Advisory Committee on murine replication-competent retrovirus (RCR) assays (February 17, 1993).

26 December 2024

2

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy

26 December 2024

3

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

Amphotropic murine leukemia retrovirus is not an acute pathogen for primates

26 December 2024

4

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus

26 December 2024

5

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

26 December 2024

6

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system

26 December 2024

7

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts

26 December 2024

8

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

26 December 2024

9

53

5274

FREEMAN S.M.

1993

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines

26 December 2024

10

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

Human gene therapy comes of age.

26 December 2024

13

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

26 December 2024

14

7

980

MILLER A.D.

1989

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

Factors involved in production of helper virus-free retrovirus vectors.

26 December 2024

15

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

Analysis of retroviral packaging lines for generation of replication-competent virus

26 December 2024

16

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

26 December 2024

17

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences

26 December 2024

18

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

Gene therapy in the United States: a five-year status report

26 December 2024

20

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

The alpha-galactosyl epitope: a sugar coating that makes viruses and cells unpalatable

26 December 2024

21

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

Safety considerations in somatic gene therapy of human disease with retrovirus vectors

26 December 2024

22

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors

26 December 2024

23

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

Bystander tumoricidal effect in the treatment of experimental brain tumors

26 December 2024

24

1 reference

https://api.crossref.org/works/10.1089/HUM.1998.9.8-1165

26 December 2024

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017